DT
Highly rated in
25
conditions
Highly rated in
25
conditions

Specialties:Oncology | Hematology | Internal Medicine
Experience:27 Years
Accepts:New PatientsMedicare
About Dr. Donald E. Tsai

Donald Tsai is an Oncologist and a Hematologist in Philadelphia, Pennsylvania. Dr. Tsai has been practicing medicine for over 27 years and is highly rated in 25 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, X-Linked Lymphoproliferative Disease, Primary Lymphoma of the Brain, and B-Cell Lymphoma. He is board certified in Hematology/oncology and licensed to treat patients in Pennsylvania. Dr. Tsai is currently accepting new patients.

His clinical research consists of co-authoring 52 peer reviewed articles and participating in 94 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Donald E. Tsai it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Call to see if your plan is accepted.
Call Now
Locations
  3400 Civic Ctr Blvd Fl 2 Philadelphia, PA 19104, US
Background & Education
Graduate Institution
Duke University School Of Medicine, 1994
Specialties
Oncology
Hematology
Internal Medicine
Licenses
Internal Medicine in PA
Board Certifications
Hematology/oncology
Hospital Affiliations
Hospital Of Univ Of Pennsylvania
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

Enrollment Status:Terminated
Study Type:Drug
Study Phase: Phase 2
A Phase II Study of Bexarotene in Patients With Acute Myeloid Leukemia
View Trial

52 Total Publications

Journal: Lancet (London, England)
Published —November 04, 2020
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.


Save this doctor for later
Sign Up
Is this your doctor?
Find a second opinion
Find Now
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors
Highly rated in
0
conditions
Hematology | Oncology | Internal Medicine
University Of Penn Medical Group
 
Philadelphia, PA 19104
 0.8 mi
Stephen Schuster is a Hematologist and an Internal Medicine specialist in Philadelphia, Pennsylvania. He has been an author on 151 peer reviewed articles and participated in 216 clinical trials in the past 15 years. He is licensed to treat patients in PA.
Highly rated in
0
conditions
Hematology | Pediatrics | Oncology
Childrens Health Care Associates Inc
3401 Civic Ctr Blvd
 
Philadelphia, PA 19104
 0.1 mi
Janet Kwiatkowski is a Hematologist and a Pediatrics specialist in Philadelphia, Pennsylvania. She has been an author on 95 peer reviewed articles and participated in 134 clinical trials in the past 15 years. She is licensed to treat patients in PA.
Highly rated in
0
conditions
Hematology | Oncology | Internal Medicine
University Of Penn Medical Group
 
Philadelphia, PA 19104
 0.8 mi
Corey Langer is a Hematologist and an Internal Medicine specialist in Philadelphia, Pennsylvania. He has been an author on 309 peer reviewed articles and participated in 44 clinical trials in the past 15 years. He is licensed to treat patients in PA.